Barclays’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
|
|||||
|
2025
Q1 | $1.71M | Sell |
|
|||||
|
2024
Q4 | $3.63M | Buy |
|
|||||
|
2024
Q3 | $6.02M | Buy |
|
|||||
|
2024
Q2 | $4.55M | Buy |
|
|||||
|
2024
Q1 | $5.1M | Sell |
|
|||||
|
2023
Q4 | $10.7M | Buy |
|
|||||
|
2023
Q3 | $8.12M | Buy |
|
|||||
|
2023
Q2 | $9.1M | Sell |
|
|||||
|
2023
Q1 | $8.41M | Sell |
|
|||||
|
2022
Q4 | $9.07M | Buy |
|
|||||
|
2022
Q3 | $10.3M | Buy |
|
|||||
|
2022
Q2 | $5.53M | Buy |
|
|||||
|
2022
Q1 | $7.33M | Sell |
|
|||||
|
2021
Q4 | $16.4M | Buy |
|
|||||
|
2021
Q3 | $10.2M | Buy |
|
|||||
|
2021
Q2 | $6.53M | Sell |
|
|||||
|
2021
Q1 | $7.45M | Buy |
|
|||||
|
2020
Q4 | $928K | Sell |
|
|||||
|
2020
Q3 | $597K | Buy |
|
|||||
|
2020
Q2 | $632K | Buy |
|
|||||
|
2020
Q1 | $320K | Sell |
|
|||||
|
2019
Q4 | $668K | Buy |
|
|||||
|
2019
Q3 | $260K | Sell |
|
|||||
|
2019
Q2 | $413K | Buy |
|
|||||
|
2019
Q1 | $162K | Sell |
|
|||||
|
2018
Q4 | $209K | Sell |
|
|||||
|
2018
Q3 | $466K | Buy |
|
|||||
|
2018
Q2 | $205K | Sell |
|
|||||
|
2018
Q1 | $416K | Buy |
|
|||||
|
2017
Q4 | $179K | Buy |
|
|||||
|
2017
Q3 | $172K | Buy |
|
|||||
|
2017
Q2 | $33K | Sell |
|
|||||
|
2017
Q1 | $267K | Buy |
|
|||||
|
2016
Q4 | $148K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $10K | Buy |
|